IMS Health Holdings (IMS) Shares are Up 2.76%

IMS Health Holdings (IMS) : Traders are bullish on IMS Health Holdings (IMS) as it has outperformed the S&P 500 by a margin of 9.06% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 2.14%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 2.76% in the last 1 week, and is up 16.43% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

IMS Health Holdings (NYSE:IMS): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $28.06 and $28.06 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $28.76. The buying momentum continued till the end and the stock did not give up its gains. It closed at $28.63, notching a gain of 1.56% for the day. The total traded volume was 1,066,664 . The stock had closed at $28.19 on the previous day.


The stock has recorded a 20-day Moving Average of 7.58% and the 50-Day Moving Average is 10.83%. IMS Health Holdings, Inc. is up 7.07% in the last 3-month period. Year-to-Date the stock performance stands at 12.41%.

IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Companys data set contains over 10 petabytes of data and over 500 million patient records. The Company serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Companys principal offerings include national information offerings, sub-national information offerings, workflow analytics, real-world evidence (RWE) solutions, technology and applications and clinical solutions.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *